+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anaplastic Thyroid Cancer Drugs Market 2024-2028

  • PDF Icon

    Report

  • 151 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5601923
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anaplastic thyroid cancer drugs market is forecasted to grow by USD 300.7 mn during 2023-2028, accelerating at a CAGR of 6.41% during the forecast period. The report on the anaplastic thyroid cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of thyroid cancer, introduction of targeted therapies, and rising geriatric population.

The anaplastic thyroid cancer drugs market is segmented as below:

By End-user

  • Hospitals
  • Clinics
  • Others

By Product

  • Chemotherapy
  • Novel therapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing awareness of thyroid cancer as one of the prime reasons driving the anaplastic thyroid cancer drugs market growth during the next few years. Also, strong pipeline in the treatment of anaplastic thyroid cancer and favorable reimbursement policies for chemotherapy will lead to sizable demand in the market.

The report on the anaplastic thyroid cancer drugs market covers the following areas:

  • Anaplastic thyroid cancer drugs market sizing
  • Anaplastic thyroid cancer drugs market forecast
  • Anaplastic thyroid cancer drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs market vendors that include Bayer AG, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Exelixis Inc., Merck KGaA, Novartis AG, and Verastem Inc.. Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global anaplastic thyroid cancer drugs market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global anaplastic thyroid cancer drugs market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Clinics - Market size and forecast 2023-2028
Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Chemotherapy - Market size and forecast 2023-2028
Exhibit 52: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
7.4 Novel therapy - Market size and forecast 2023-2028
Exhibit 56: Chart on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Novel therapy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Novel therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Italy - Market size and forecast 2023-2028
Exhibit 87: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Italy - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key news
Exhibit 114: Bayer AG - Key offerings
Exhibit 115: Bayer AG - Segment focus
12.4 Bristol Myers Squibb Co.
Exhibit 116: Bristol Myers Squibb Co. - Overview
Exhibit 117: Bristol Myers Squibb Co. - Product / Service
Exhibit 118: Bristol Myers Squibb Co. - Key news
Exhibit 119: Bristol Myers Squibb Co. - Key offerings
12.5 Daiichi Sankyo Co. Ltd.
Exhibit 120: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 121: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 122: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 123: Daiichi Sankyo Co. Ltd. - Key offerings
12.6 Eisai Co. Ltd.
Exhibit 124: Eisai Co. Ltd. - Overview
Exhibit 125: Eisai Co. Ltd. - Business segments
Exhibit 126: Eisai Co. Ltd. - Key offerings
Exhibit 127: Eisai Co. Ltd. - Segment focus
12.7 Exelixis Inc.
Exhibit 128: Exelixis Inc. - Overview
Exhibit 129: Exelixis Inc. - Product / Service
Exhibit 130: Exelixis Inc. - Key offerings
12.8 Merck KGaA
Exhibit 131: Merck KGaA - Overview
Exhibit 132: Merck KGaA - Business segments
Exhibit 133: Merck KGaA - Key news
Exhibit 134: Merck KGaA - Key offerings
Exhibit 135: Merck KGaA - Segment focus
12.9 Novartis AG
Exhibit 136: Novartis AG - Overview
Exhibit 137: Novartis AG - Business segments
Exhibit 138: Novartis AG - Key offerings
Exhibit 139: Novartis AG - Segment focus
12.10 Verastem Inc.
Exhibit 140: Verastem Inc. - Overview
Exhibit 141: Verastem Inc. - Product / Service
Exhibit 142: Verastem Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 143: Inclusions checklist
Exhibit 144: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 145: Currency conversion rates for US$
13.4 Research methodology
Exhibit 146: Research methodology
Exhibit 147: Validation techniques employed for market sizing
Exhibit 148: Information sources
13.5 List of abbreviations
Exhibit 149: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global anaplastic thyroid cancer drugs market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Product - Market share 2023-2028 (%)
Exhibits 49: Data Table on Product - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Product
Exhibits 51: Data Table on Comparison by Product
Exhibits 52: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Novel therapy - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Novel therapy - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by Product ($ million)
Exhibits 61: Data Table on Market opportunity by Product ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Italy - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Bayer AG - Overview
Exhibits 112: Bayer AG - Business segments
Exhibits 113: Bayer AG - Key news
Exhibits 114: Bayer AG - Key offerings
Exhibits 115: Bayer AG - Segment focus
Exhibits 116: Bristol Myers Squibb Co. - Overview
Exhibits 117: Bristol Myers Squibb Co. - Product / Service
Exhibits 118: Bristol Myers Squibb Co. - Key news
Exhibits 119: Bristol Myers Squibb Co. - Key offerings
Exhibits 120: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 121: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 122: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 123: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 124: Eisai Co. Ltd. - Overview
Exhibits 125: Eisai Co. Ltd. - Business segments
Exhibits 126: Eisai Co. Ltd. - Key offerings
Exhibits 127: Eisai Co. Ltd. - Segment focus
Exhibits 128: Exelixis Inc. - Overview
Exhibits 129: Exelixis Inc. - Product / Service
Exhibits 130: Exelixis Inc. - Key offerings
Exhibits 131: Merck KGaA - Overview
Exhibits 132: Merck KGaA - Business segments
Exhibits 133: Merck KGaA - Key news
Exhibits 134: Merck KGaA - Key offerings
Exhibits 135: Merck KGaA - Segment focus
Exhibits 136: Novartis AG - Overview
Exhibits 137: Novartis AG - Business segments
Exhibits 138: Novartis AG - Key offerings
Exhibits 139: Novartis AG - Segment focus
Exhibits 140: Verastem Inc. - Overview
Exhibits 141: Verastem Inc. - Product / Service
Exhibits 142: Verastem Inc. - Key offerings
Exhibits 143: Inclusions checklist
Exhibits 144: Exclusions checklist
Exhibits 145: Currency conversion rates for US$
Exhibits 146: Research methodology
Exhibits 147: Validation techniques employed for market sizing
Exhibits 148: Information sources
Exhibits 149: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global anaplastic thyroid cancer drugs market: Bayer AG, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Exelixis Inc., Merck KGaA, Novartis AG, and Verastem Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing awareness of thyroid cancer.'

According to the report, one of the major drivers for this market is the high prevalence of thyroid cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • Exelixis Inc.
  • Merck KGaA
  • Novartis AG
  • Verastem Inc.